Literature DB >> 26352396

HIV treatment cascade in migrants and mobile populations.

Frank Tanser1, Till Bärnighausen, Alain Vandormael, Adrian Dobra.   

Abstract

PURPOSE OF REVIEW: Health policy makers aspire to achieve an HIV treatment 'cascade' in which diagnostic and treatment services are accessed early and routinely by HIV-infected individuals. However, migrants and highly mobile individuals are likely to interact with HIV treatment programs and the healthcare system in ways that reflect their movement through time and place, affecting their successful progression through the HIV treatment cascade. We review recent research that has examined the challenges in effective and sustained HIV treatment for migrants and mobile populations. RECENT
FINDINGS: Mobility is associated with increased risk of antiretroviral therapy (ART) nonadherence, lost to follow-up, deterioration in CD4 count, HIV-related death, development of drug resistance and general noncontinuity of HIV care. Migrants' slow progression through the HIV treatment cascade can be attributed to feelings of confusion, helplessness; an inability to effectively communicate in the native language; poor knowledge about administrative or logistical requirements of the healthcare system; the possibility of deportation or expulsion based on the legal status of the undocumented migrant; fear of disclosure and social isolation from the exile or compatriot group. Travel or transition to the host country commonly makes it difficult for migrants to remain enrolled in ART programs and to maintain adherence to treatment.
SUMMARY: Existing public health systems fail to properly account for migration, and actionable knowledge of the health requirements of migrants is still lacking. A large body of research has shown that migrants are more likely to enter into the healthcare system late and are less likely to be retained at successive stages of the HIV treatment cascade. HIV-infected migrants are especially vulnerable to a wide range of social, economic and political factors that include a lack of direct access to healthcare services; exposure to difficult or oppressive work environments; the separation from family, friends and a familiar sociocultural environment. Realizing the full treatment and preventive benefits of the UNAIDS 90-90-90 strategy will require reaching all marginalized subpopulations of which migrants are a particularly large and important group.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26352396     DOI: 10.1097/COH.0000000000000192

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  52 in total

Review 1.  Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies.

Authors:  Kobus Herbst; Matthew Law; Pascal Geldsetzer; Frank Tanser; Guy Harling; Till Bärnighausen
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

Review 2.  Prevalence rates of six selected infectious diseases among African migrants and refugees: a systematic review and meta-analysis.

Authors:  A Chernet; J Utzinger; V Sydow; N Probst-Hensch; D H Paris; N D Labhardt; A Neumayr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-28       Impact factor: 3.267

3.  Changes in Health and Antiretroviral Adherence Among HIV-Infected Adults in Kenya: Qualitative Longitudinal Findings from a Livelihood Intervention.

Authors:  Sheri D Weiser; Abigail M Hatcher; Lee L Hufstedler; Elly Weke; Shari L Dworkin; Elizabeth A Bukusi; Rachel L Burger; Stephen Kodish; Nils Grede; Lisa M Butler; Craig R Cohen
Journal:  AIDS Behav       Date:  2017-02

4.  Precision public health and HIV in Africa.

Authors:  Sally Blower; Justin T Okano
Journal:  Lancet Infect Dis       Date:  2019-10       Impact factor: 25.071

5.  Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa.

Authors:  Carol S Camlin; Adam Akullian; Torsten B Neilands; Monica Getahun; Anna Bershteyn; Sarah Ssali; Elvin Geng; Monica Gandhi; Craig R Cohen; Irene Maeri; Patrick Eyul; Maya L Petersen; Diane V Havlir; Moses R Kamya; Elizabeth A Bukusi; Edwin D Charlebois
Journal:  Health Place       Date:  2019-05-29       Impact factor: 4.078

6.  High percentage of undiagnosed HIV cases within a hyperendemic South African community: a population-based study.

Authors:  Alain Vandormael; Tulio de Oliveira; Frank Tanser; Till Bärnighausen; Joshua T Herbeck
Journal:  J Epidemiol Community Health       Date:  2017-11-24       Impact factor: 3.710

7.  Chronicity, crisis, and the 'end of AIDS'.

Authors:  Thurka Sangaramoorthy
Journal:  Glob Public Health       Date:  2018-01-11

8.  Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity.

Authors:  Shashi N Kapadia; Carrie D Johnston; Kristen M Marks; Bruce R Schackman; Erika G Martin
Journal:  J Public Health Manag Pract       Date:  2019 May/Jun

9.  Patient engagement in HIV care and treatment in Zambia, 2004-2014.

Authors:  Neo Christopher Chung; Carolyn Bolton-Moore; Roma Chilengi; Margaret P Kasaro; Jeffrey S A Stringer; Benjamin H Chi
Journal:  Trop Med Int Health       Date:  2017-01-19       Impact factor: 2.622

10.  Social Disequilibrium and the Risk of HIV Acquisition: A Multilevel Study in Rural KwaZulu-Natal Province, South Africa.

Authors:  Andrew Tomita; Alain M Vandormael; Till Bärnighausen; Tulio de Oliveira; Frank Tanser
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.